Natural history of sesame allergy in pediatric patients: Insight from a retrospective analysis.

IF 4.3 2区 医学 Q2 ALLERGY
Alp Kazancioglu, Melike Ocak, Umit Murat Sahiner, Ozge Soyer, Bulent Enis Sekerel
{"title":"Natural history of sesame allergy in pediatric patients: Insight from a retrospective analysis.","authors":"Alp Kazancioglu, Melike Ocak, Umit Murat Sahiner, Ozge Soyer, Bulent Enis Sekerel","doi":"10.1111/pai.70022","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sesame allergy (SA) is a growing concern because of its association with severe reactions and the limited knowledge of long-term outcomes.</p><p><strong>Objective: </strong>This retrospective study aimed to identify the risk factors influencing persistent SA (PSA) in children to improve management and select suitable candidates for oral immunotherapy (OIT).</p><p><strong>Methods: </strong>We analyzed the electronic medical records of 84 children with confirmed SA, as defined by consistent clinical reactions and immunoglobulin E (IgE)-mediated sensitization. Patients were followed for a median (IQR) of 56.5 (46.0-82.5) months.</p><p><strong>Results: </strong>Most participants were male (72.6%) with concurrent food allergies (71.4%). They experienced a median (IQR) of 3.0 (2.0-3.7) allergic episodes, with 46.4% experiencing at least one anaphylactic reaction. PSA was observed in 82.1% (69/84) of the patients. A larger skin prick test (SPT) wheal size at the first reaction (adjusted OR = 1.79, CI:1.05-3.04; p = .03) and allergic reaction grade≥2 (adjusted OR = 19.93, CI:1.37-289.13; p = .02) were independent risk factors for persistence. A 3-fold increase in the likelihood of persistence was observed in patients with SPT results greater than 6.7 mm at first reaction compared with those with results less than 6.7 mm during follow-up (HR = 3.08; CI:1.17-8.12; p = .02). Patients with sustained or increased SPT wheal size (93% remained allergic) and specific IgE (95% remained allergic) at the final visit were more likely to have PSA, whereas those with decreased levels (37% and 39% developed natural tolerance, respectively) were less likely to have resolved SA.</p><p><strong>Conclusions: </strong>This study identified novel risk factors for PSA, including SPT wheal size at the first reaction, reaction severity, and sustained sensitization markers. These findings can inform management strategies and the selection of OIT candidates. Further long-term studies are crucial to elucidate the natural history of SA across populations and to evaluate early interventions, such as OIT.</p>","PeriodicalId":19929,"journal":{"name":"Pediatric Allergy and Immunology","volume":"36 1","pages":"e70022"},"PeriodicalIF":4.3000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11736677/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Allergy and Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/pai.70022","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Sesame allergy (SA) is a growing concern because of its association with severe reactions and the limited knowledge of long-term outcomes.

Objective: This retrospective study aimed to identify the risk factors influencing persistent SA (PSA) in children to improve management and select suitable candidates for oral immunotherapy (OIT).

Methods: We analyzed the electronic medical records of 84 children with confirmed SA, as defined by consistent clinical reactions and immunoglobulin E (IgE)-mediated sensitization. Patients were followed for a median (IQR) of 56.5 (46.0-82.5) months.

Results: Most participants were male (72.6%) with concurrent food allergies (71.4%). They experienced a median (IQR) of 3.0 (2.0-3.7) allergic episodes, with 46.4% experiencing at least one anaphylactic reaction. PSA was observed in 82.1% (69/84) of the patients. A larger skin prick test (SPT) wheal size at the first reaction (adjusted OR = 1.79, CI:1.05-3.04; p = .03) and allergic reaction grade≥2 (adjusted OR = 19.93, CI:1.37-289.13; p = .02) were independent risk factors for persistence. A 3-fold increase in the likelihood of persistence was observed in patients with SPT results greater than 6.7 mm at first reaction compared with those with results less than 6.7 mm during follow-up (HR = 3.08; CI:1.17-8.12; p = .02). Patients with sustained or increased SPT wheal size (93% remained allergic) and specific IgE (95% remained allergic) at the final visit were more likely to have PSA, whereas those with decreased levels (37% and 39% developed natural tolerance, respectively) were less likely to have resolved SA.

Conclusions: This study identified novel risk factors for PSA, including SPT wheal size at the first reaction, reaction severity, and sustained sensitization markers. These findings can inform management strategies and the selection of OIT candidates. Further long-term studies are crucial to elucidate the natural history of SA across populations and to evaluate early interventions, such as OIT.

儿科患者芝麻过敏的自然史:回顾性分析的见解。
背景:芝麻过敏(SA)是一个日益受到关注的问题,因为它与严重的反应和对长期结果的有限了解有关。目的:本回顾性研究旨在确定影响儿童持续性SA (PSA)的危险因素,以改善治疗和选择合适的口服免疫治疗(OIT)候选人。方法:我们分析了84例确诊SA患儿的电子病历,以一致的临床反应和免疫球蛋白E (IgE)介导的致敏性来定义。患者随访的中位(IQR)为56.5(46.0-82.5)个月。结果:大多数参与者为男性(72.6%),同时伴有食物过敏(71.4%)。他们经历了3.0(2.0-3.7)的中位(IQR)过敏发作,46.4%经历了至少一次过敏反应。82.1%(69/84)的患者出现PSA。首次反应时较大的皮肤点刺试验(SPT)轮大小(校正OR = 1.79, CI:1.05-3.04;p = .03),过敏反应等级≥2(调整后OR = 19.93, CI:1.37 ~ 289.13;P = .02)是持续性的独立危险因素。与随访期间SPT结果小于6.7 mm的患者相比,首次反应时SPT结果大于6.7 mm的患者持续存在的可能性增加了3倍(HR = 3.08;置信区间:1.17—-8.12;p = .02)。在最后一次就诊时,持续或增加的SPT轮大小(93%仍然过敏)和特异性IgE(95%仍然过敏)的患者更有可能患有PSA,而水平降低的患者(分别为37%和39%产生自然耐受性)不太可能解决SA。结论:本研究确定了PSA的新危险因素,包括首次反应时SPT轮大小、反应严重程度和持续致敏标志物。这些发现可以为管理策略和OIT候选人的选择提供信息。进一步的长期研究对于阐明人群中SA的自然历史和评估早期干预措施(如OIT)至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
9.10
自引率
9.10%
发文量
200
审稿时长
4-8 weeks
期刊介绍: Pediatric Allergy and Immunology is the world''s leading journal in pediatric allergy, publishing original contributions and comprehensive reviews related to the understanding and treatment of immune deficiency and allergic inflammatory and infectious diseases in children. Other areas of interest include: development of specific and accessory immunity; the immunological interaction during pregnancy and lactation between mother and child. As Pediatric Allergy and Immunology promotes communication between scientists engaged in basic research and clinicians working with children, we publish both clinical and experimental work.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信